Ebola Hemorrhagic Fever: Recent Update On Disease Status, Current Therapies And Advances In Treatment
Open Access
- 2 November 2017
- journal article
- Published by Chitkara University Publications in Journal of Pharmaceutical Technology, Research and Management
- Vol. 5 (2), 217-234
- https://doi.org/10.15415/jptrm.2017.52013
Abstract
Swiftly growing viruses are a major intimidation to human health. Such viruses are extremely pathogenic like Ebola virus, influenza virus, HIV virus, Zika virus etc . Ebola virus, a type of Filovirus, is an extremely infectious, single-stranded ribonucleic acid virus that infects both humans and apes, prompting acute fever with hemorrhagic syndrome. The high infectivity, severity and mortality of Ebola has plagued the world for the past fifty years with its first outbreak in 1976 in Marburg, Germany, and Frankfurt along with Belgrade and Serbia. The world has perceived about 28,000 cases and over 11,000 losses. The high lethality of Ebola makes it a candidate for use in bioterrorism thereby arising more concern. New guidelines have been framed for providing best possible care to the patients suffering from Ebola virus i.e Grading of Recommendation Assessment, Development And Evaluation (GRADE) methodology to develop evidence-based strategy for the treatment in future outbreak of Ebola virus. No drugs have been approved, while many potent drugs like rVSV-EBOV, Favipiravir, ZMapp are on clinical test for human safety. In this review we will discover and discuss perspective aspects that lead to the evolution of different Ebola variants as well as advances in various drugs and vaccines for treatment of the disease.Keywords
This publication has 66 references indexed in Scilit:
- FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus InfectionScience Translational Medicine, 2013
- Transmission of Ebola virus from pigs to non-human primatesScientific Reports, 2012
- Clinical Management of Filovirus-Infected PatientsViruses, 2012
- Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for AfricaClinical Microbiology & Infection, 2011
- Tackling Ebola: new insights into prophylactic and therapeutic intervention strategiesGenome Medicine, 2011
- Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit1Emerging Infectious Diseases, 2008
- Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear AccumulationJournal of Virology, 2006
- Ebola Hemorrhagic Fever Transmission and Risk Factors of Contacts, Uganda1Emerging Infectious Diseases, 2003
- Ebola Hemorrhagic Fever Outbreaks in Gabon, 1994–1997: Epidemiologic and Health Control IssuesThe Journal of Infectious Diseases, 1999
- The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995The Journal of Infectious Diseases, 1999